tradingkey.logo
tradingkey.logo
Buscar

NeuroOne Medical Technologies Corp

NMTC
Añadir a la lista de seguimiento
4.210USD
-0.390-8.48%
Cierre 05/15, 16:00ETCotizaciones retrasadas 15 min
36.29MCap. mercado
PérdidaP/E TTM

NeuroOne Medical Technologies Corp

4.210
-0.390-8.48%

Más Datos de NeuroOne Medical Technologies Corp Compañía

NeuroOne Medical Technologies Corporation is a medical technology company. It is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.

Información de NeuroOne Medical Technologies Corp

Símbolo de cotizaciónNMTC
Nombre de la empresaNeuroOne Medical Technologies Corp
Fecha de salida a bolsaNov 09, 2012
Director ejecutivoRosa (David A)
Número de empleados17
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 09
Dirección7599 Anagram Dr
CiudadEDEN PRAIRIE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal55344-7399
Teléfono19524261383
Sitio Webhttps://nmtc1.com/
Símbolo de cotizaciónNMTC
Fecha de salida a bolsaNov 09, 2012
Director ejecutivoRosa (David A)

Ejecutivos de NeuroOne Medical Technologies Corp

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. David A. (Dave) Rosa
Mr. David A. (Dave) Rosa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
123.37K
-0.33%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Chairman of the Board
Independent Chairman of the Board
40.60K
+17.21%
Mr. Mark Christianson
Mr. Mark Christianson
Co-Founder, Business Development Director, Medical Sales Liaison
Co-Founder, Business Development Director, Medical Sales Liaison
33.11K
-15.23%
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Independent Director
Independent Director
24.17K
+28.92%
Mr. Edward (Ed) Andrle
Mr. Edward (Ed) Andrle
Independent Director
Independent Director
22.32K
+31.31%
Mr. Steve Mertens
Mr. Steve Mertens
Chief Technology Officer
Chief Technology Officer
15.43K
-0.98%
Mr. Ronald (Ron) Mcclurg
Mr. Ronald (Ron) Mcclurg
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Christopher R. Volker
Mr. Christopher R. Volker
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Emily Johns
Ms. Emily Johns
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
--
--
Mr. Chris Donovan
Mr. Chris Donovan
Investor Relations
Investor Relations
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. David A. (Dave) Rosa
Mr. David A. (Dave) Rosa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
123.37K
-0.33%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Chairman of the Board
Independent Chairman of the Board
40.60K
+17.21%
Mr. Mark Christianson
Mr. Mark Christianson
Co-Founder, Business Development Director, Medical Sales Liaison
Co-Founder, Business Development Director, Medical Sales Liaison
33.11K
-15.23%
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Independent Director
Independent Director
24.17K
+28.92%
Mr. Edward (Ed) Andrle
Mr. Edward (Ed) Andrle
Independent Director
Independent Director
22.32K
+31.31%
Mr. Steve Mertens
Mr. Steve Mertens
Chief Technology Officer
Chief Technology Officer
15.43K
-0.98%

Desglose de ingresos

La empresa aún no ha revelado los datos relevantes.
La empresa aún no ha revelado los datos relevantes.
Por negocio
Por región
La empresa aún no ha revelado los datos relevantes.

Estadísticas de accionistas

Actualizado: dom., 10 de may
Actualizado: dom., 10 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Merchant Adventure Fund LP
8.12%
Bleichroeder LP
7.73%
Bard Associates Inc.
3.56%
Perkins Capital Management, Inc.
2.85%
Vanguard Capital Management, LLC
2.70%
Otro
75.04%
Accionistas
Accionistas
Proporción
Merchant Adventure Fund LP
8.12%
Bleichroeder LP
7.73%
Bard Associates Inc.
3.56%
Perkins Capital Management, Inc.
2.85%
Vanguard Capital Management, LLC
2.70%
Otro
75.04%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
18.60%
Corporation
8.31%
Individual Investor
5.89%
Hedge Fund
3.86%
Investment Advisor/Hedge Fund
2.13%
Research Firm
0.18%
Venture Capital
0.17%
Bank and Trust
0.04%
Otro
60.82%

Participación institucional

Actualizado: mié., 1 de abr
Actualizado: mié., 1 de abr
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2026Q1
58
2.36M
28.07%
-230.40K
2025Q4
52
16.89M
33.49%
-598.07K
2025Q3
51
17.15M
34.30%
+9.56M
2025Q2
52
13.28M
26.66%
+2.81M
2025Q1
54
11.51M
24.26%
+968.46K
2024Q4
55
12.46M
40.67%
+1.38M
2024Q3
55
11.22M
39.84%
+2.23M
2024Q2
51
10.72M
41.07%
+2.35M
2024Q1
52
11.45M
45.01%
+2.75M
2023Q4
57
9.37M
38.68%
+871.77K
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Merchant Adventure Fund LP
4.20M
8.29%
--
--
Dec 31, 2025
Bleichroeder LP
4.00M
7.89%
--
--
Dec 31, 2025
Bard Associates Inc.
1.85M
3.64%
-4.00K
-0.22%
Dec 31, 2025
Perkins Capital Management, Inc.
1.47M
2.91%
+5.00K
+0.34%
Dec 31, 2025
Sio Capital Management, LLC
1.14M
2.25%
-1.22M
-51.71%
Dec 31, 2025
Renaissance Technologies LLC
763.03K
1.51%
+70.43K
+10.17%
Dec 31, 2025
Rosa (David A)
745.12K
1.47%
-71.33K
-8.74%
Feb 18, 2026
Geode Capital Management, L.L.C.
504.51K
1%
+7.68K
+1.54%
Dec 31, 2025
Ver más

ETFs relacionados

Nombre
Proporción
Sin datos

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Apr 14, 2026
Merger
6→1
Fecha
Fecha ex-dividendo
Tipo
Relación
Apr 14, 2026
Merger
6→1
KeyAI